Table 1.
Samples sizes required for PROTECTS to have 80% power to detect an effect of 0.25 in patients who consent to treatment, under both cmRCT and pRCT designs
| Percentage of patients consenting to trial | cmRCT |
pRCT |
||||||
|---|---|---|---|---|---|---|---|---|
| Effect size to be detected (adjusted for consent rate) | Patients selected | Patients consented | Patients in treatment vs. control arms | Effect size to be detected | Patients invited | Patients consented | Patients in treatment vs. control arms | |
| 100% | 0.25 | 139 | 139 | 139 vs. 1167 | 0.25 | 504 | 504 | 252 vs. 252 |
| 90% | 0.225 | 178 | 160 | 178 vs. 1128 | 0.25 | 560 | 504 | 252 vs. 252 |
| 80% | 0.2 | 237 | 190 | 237 vs. 1069 | 0.25 | 630 | 504 | 252 vs. 252 |
| 70% | 0.175 | 344 | 241 | 344 vs. 962 | 0.25 | 720 | 504 | 252 vs. 252 |
| 62% | 0.155 | 653 | 405 | 653 vs. 653 | 0.25 | 813 | 504 | 252 vs. 252 |
| 60% | <80% power | 0.25 | 840 | 504 | 252 vs. 252 | |||
| 50% | <80% power | 0.25 | 1008 | 504 | 252 vs. 252 | |||
| 40% | <80% power | 0.25 | 1260 | 504 | 252 vs. 252 | |||
Abbreviations: cmRCT, cohort multiple randomized controlled trial; pRCT, pragmatic RCT.